The following amendment has been made to the 'Transaction in Own Shares' announcement released on 09/06/2025 at 07:00 under RNS No 8791L
The Company purchased shares to hold in treasury on 6 June 2025 not 6 May 2025, and the date has been updated accordingly. All other details remain unchanged.
The full amended text is shown below.
|
Bellevue Healthcare Trust plc |
|
|
|
|
|
Transaction in own shares |
|
|
|
|
|
Bellevue Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each on the London Stock Exchange through J.P. Morgan Securities plc. |
|
|
|
|
|
Date of purchase: |
06 June 2025 |
|
Number of ordinary shares purchased: |
1,182,840 |
|
Trading venue |
LSE |
|
Average price paid per share: |
120.53p |
|
|
|
|
The Company intends to hold the purchased shares in treasury. |
|
|
|
|
|
Following the above transaction, the Company holds 122,908,669 of its ordinary shares in treasury and has 192,243,640 ordinary shares in issue (excluding treasury shares). |
|
|
|
|
|
The Company's LEI is: 213800HQ3J3H9YF2UI82 |
|
|
|
|
|
Enquiries: |
|
|
Bellevue Asset Management (UK) Ltd. |
|
|
Mark Ghahramani |
|
|
Telephone: +44 (0) 203 326 2981 |
|
|
|
|
|
J.P. Morgan Cazenove |
|
|
James Bouverat (Sales) |
|
|
Telephone: +44 (0) 207 134 2224 |
|
|
|
|
|
NSM Funds (UK) Limited |
|
|
Brian Smith, Ciara McKillop |
|
|
Contact: bellevue@nsm.group |
|